Global IVD Infectious Diseases Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global IVD Infectious Diseases market size was valued at USD 17100 million in 2023 and is forecast to a readjusted size of USD 21950 million by 2030 with a CAGR of 3.6% during review period.
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
The Global Info Research report includes an overview of the development of the IVD Infectious Diseases industry chain, the market status of Clinical Laboratories (Immunochemistry, Molecular Diagnostics), Diagnostic Centers (Immunochemistry, Molecular Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVD Infectious Diseases.
Regionally, the report analyzes the IVD Infectious Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVD Infectious Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVD Infectious Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVD Infectious Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunochemistry, Molecular Diagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVD Infectious Diseases market.
Regional Analysis: The report involves examining the IVD Infectious Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVD Infectious Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVD Infectious Diseases:
Company Analysis: Report covers individual IVD Infectious Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVD Infectious Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Laboratories, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to IVD Infectious Diseases. It assesses the current state, advancements, and potential future developments in IVD Infectious Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVD Infectious Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVD Infectious Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe IVD Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD Infectious Diseases, with revenue, gross margin and global market share of IVD Infectious Diseases from 2019 to 2024.
Chapter 3, the IVD Infectious Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVD Infectious Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD Infectious Diseases.
Chapter 13, to describe IVD Infectious Diseases research findings and conclusion.
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
The Global Info Research report includes an overview of the development of the IVD Infectious Diseases industry chain, the market status of Clinical Laboratories (Immunochemistry, Molecular Diagnostics), Diagnostic Centers (Immunochemistry, Molecular Diagnostics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVD Infectious Diseases.
Regionally, the report analyzes the IVD Infectious Diseases markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVD Infectious Diseases market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVD Infectious Diseases market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVD Infectious Diseases industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immunochemistry, Molecular Diagnostics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVD Infectious Diseases market.
Regional Analysis: The report involves examining the IVD Infectious Diseases market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVD Infectious Diseases market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVD Infectious Diseases:
Company Analysis: Report covers individual IVD Infectious Diseases players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVD Infectious Diseases This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Laboratories, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to IVD Infectious Diseases. It assesses the current state, advancements, and potential future developments in IVD Infectious Diseases areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVD Infectious Diseases market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVD Infectious Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Immunochemistry
- Molecular Diagnostics
- Clinical Laboratories
- Diagnostic Centers
- BD
- BioMerieux
- Abbott
- Quidel
- Gen-Probe
- Abbott
- Danaher
- Sysmex
- Orasure
- Hologic
- Cepheid
- Qiagen
- Roche Diagnostics
- Siemens Healthcare
- Bio-Rad Laboratories
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe IVD Infectious Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD Infectious Diseases, with revenue, gross margin and global market share of IVD Infectious Diseases from 2019 to 2024.
Chapter 3, the IVD Infectious Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVD Infectious Diseases market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD Infectious Diseases.
Chapter 13, to describe IVD Infectious Diseases research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of IVD Infectious Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVD Infectious Diseases by Type
1.3.1 Overview: Global IVD Infectious Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IVD Infectious Diseases Consumption Value Market Share by Type in 2023
1.3.3 Immunochemistry
1.3.4 Molecular Diagnostics
1.4 Global IVD Infectious Diseases Market by Application
1.4.1 Overview: Global IVD Infectious Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical Laboratories
1.4.3 Diagnostic Centers
1.5 Global IVD Infectious Diseases Market Size & Forecast
1.6 Global IVD Infectious Diseases Market Size and Forecast by Region
1.6.1 Global IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IVD Infectious Diseases Market Size by Region, (2019-2030)
1.6.3 North America IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.4 Europe IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.6 South America IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IVD Infectious Diseases Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD IVD Infectious Diseases Product and Solutions
2.1.4 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments and Future Plans
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business
2.2.3 BioMerieux IVD Infectious Diseases Product and Solutions
2.2.4 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMerieux Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott IVD Infectious Diseases Product and Solutions
2.3.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Quidel
2.4.1 Quidel Details
2.4.2 Quidel Major Business
2.4.3 Quidel IVD Infectious Diseases Product and Solutions
2.4.4 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Quidel Recent Developments and Future Plans
2.5 Gen-Probe
2.5.1 Gen-Probe Details
2.5.2 Gen-Probe Major Business
2.5.3 Gen-Probe IVD Infectious Diseases Product and Solutions
2.5.4 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Gen-Probe Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott IVD Infectious Diseases Product and Solutions
2.6.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Danaher
2.7.1 Danaher Details
2.7.2 Danaher Major Business
2.7.3 Danaher IVD Infectious Diseases Product and Solutions
2.7.4 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Danaher Recent Developments and Future Plans
2.8 Sysmex
2.8.1 Sysmex Details
2.8.2 Sysmex Major Business
2.8.3 Sysmex IVD Infectious Diseases Product and Solutions
2.8.4 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sysmex Recent Developments and Future Plans
2.9 Orasure
2.9.1 Orasure Details
2.9.2 Orasure Major Business
2.9.3 Orasure IVD Infectious Diseases Product and Solutions
2.9.4 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Orasure Recent Developments and Future Plans
2.10 Hologic
2.10.1 Hologic Details
2.10.2 Hologic Major Business
2.10.3 Hologic IVD Infectious Diseases Product and Solutions
2.10.4 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Hologic Recent Developments and Future Plans
2.11 Cepheid
2.11.1 Cepheid Details
2.11.2 Cepheid Major Business
2.11.3 Cepheid IVD Infectious Diseases Product and Solutions
2.11.4 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cepheid Recent Developments and Future Plans
2.12 Qiagen
2.12.1 Qiagen Details
2.12.2 Qiagen Major Business
2.12.3 Qiagen IVD Infectious Diseases Product and Solutions
2.12.4 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qiagen Recent Developments and Future Plans
2.13 Roche Diagnostics
2.13.1 Roche Diagnostics Details
2.13.2 Roche Diagnostics Major Business
2.13.3 Roche Diagnostics IVD Infectious Diseases Product and Solutions
2.13.4 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Roche Diagnostics Recent Developments and Future Plans
2.14 Siemens Healthcare
2.14.1 Siemens Healthcare Details
2.14.2 Siemens Healthcare Major Business
2.14.3 Siemens Healthcare IVD Infectious Diseases Product and Solutions
2.14.4 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Siemens Healthcare Recent Developments and Future Plans
2.15 Bio-Rad Laboratories
2.15.1 Bio-Rad Laboratories Details
2.15.2 Bio-Rad Laboratories Major Business
2.15.3 Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions
2.15.4 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IVD Infectious Diseases Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IVD Infectious Diseases by Company Revenue
3.2.2 Top 3 IVD Infectious Diseases Players Market Share in 2023
3.2.3 Top 6 IVD Infectious Diseases Players Market Share in 2023
3.3 IVD Infectious Diseases Market: Overall Company Footprint Analysis
3.3.1 IVD Infectious Diseases Market: Region Footprint
3.3.2 IVD Infectious Diseases Market: Company Product Type Footprint
3.3.3 IVD Infectious Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IVD Infectious Diseases Consumption Value and Market Share by Type (2019-2024)
4.2 Global IVD Infectious Diseases Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IVD Infectious Diseases Consumption Value Market Share by Application (2019-2024)
5.2 Global IVD Infectious Diseases Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America IVD Infectious Diseases Consumption Value by Type (2019-2030)
6.2 North America IVD Infectious Diseases Consumption Value by Application (2019-2030)
6.3 North America IVD Infectious Diseases Market Size by Country
6.3.1 North America IVD Infectious Diseases Consumption Value by Country (2019-2030)
6.3.2 United States IVD Infectious Diseases Market Size and Forecast (2019-2030)
6.3.3 Canada IVD Infectious Diseases Market Size and Forecast (2019-2030)
6.3.4 Mexico IVD Infectious Diseases Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe IVD Infectious Diseases Consumption Value by Type (2019-2030)
7.2 Europe IVD Infectious Diseases Consumption Value by Application (2019-2030)
7.3 Europe IVD Infectious Diseases Market Size by Country
7.3.1 Europe IVD Infectious Diseases Consumption Value by Country (2019-2030)
7.3.2 Germany IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.3 France IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.5 Russia IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.6 Italy IVD Infectious Diseases Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region
8.3.1 Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2019-2030)
8.3.2 China IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.3 Japan IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.4 South Korea IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.5 India IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.7 Australia IVD Infectious Diseases Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America IVD Infectious Diseases Consumption Value by Type (2019-2030)
9.2 South America IVD Infectious Diseases Consumption Value by Application (2019-2030)
9.3 South America IVD Infectious Diseases Market Size by Country
9.3.1 South America IVD Infectious Diseases Consumption Value by Country (2019-2030)
9.3.2 Brazil IVD Infectious Diseases Market Size and Forecast (2019-2030)
9.3.3 Argentina IVD Infectious Diseases Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country
10.3.1 Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2019-2030)
10.3.2 Turkey IVD Infectious Diseases Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IVD Infectious Diseases Market Size and Forecast (2019-2030)
10.3.4 UAE IVD Infectious Diseases Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 IVD Infectious Diseases Market Drivers
11.2 IVD Infectious Diseases Market Restraints
11.3 IVD Infectious Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IVD Infectious Diseases Industry Chain
12.2 IVD Infectious Diseases Upstream Analysis
12.3 IVD Infectious Diseases Midstream Analysis
12.4 IVD Infectious Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of IVD Infectious Diseases
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVD Infectious Diseases by Type
1.3.1 Overview: Global IVD Infectious Diseases Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IVD Infectious Diseases Consumption Value Market Share by Type in 2023
1.3.3 Immunochemistry
1.3.4 Molecular Diagnostics
1.4 Global IVD Infectious Diseases Market by Application
1.4.1 Overview: Global IVD Infectious Diseases Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical Laboratories
1.4.3 Diagnostic Centers
1.5 Global IVD Infectious Diseases Market Size & Forecast
1.6 Global IVD Infectious Diseases Market Size and Forecast by Region
1.6.1 Global IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IVD Infectious Diseases Market Size by Region, (2019-2030)
1.6.3 North America IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.4 Europe IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.6 South America IVD Infectious Diseases Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IVD Infectious Diseases Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD IVD Infectious Diseases Product and Solutions
2.1.4 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments and Future Plans
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business
2.2.3 BioMerieux IVD Infectious Diseases Product and Solutions
2.2.4 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMerieux Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott IVD Infectious Diseases Product and Solutions
2.3.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Quidel
2.4.1 Quidel Details
2.4.2 Quidel Major Business
2.4.3 Quidel IVD Infectious Diseases Product and Solutions
2.4.4 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Quidel Recent Developments and Future Plans
2.5 Gen-Probe
2.5.1 Gen-Probe Details
2.5.2 Gen-Probe Major Business
2.5.3 Gen-Probe IVD Infectious Diseases Product and Solutions
2.5.4 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Gen-Probe Recent Developments and Future Plans
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business
2.6.3 Abbott IVD Infectious Diseases Product and Solutions
2.6.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abbott Recent Developments and Future Plans
2.7 Danaher
2.7.1 Danaher Details
2.7.2 Danaher Major Business
2.7.3 Danaher IVD Infectious Diseases Product and Solutions
2.7.4 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Danaher Recent Developments and Future Plans
2.8 Sysmex
2.8.1 Sysmex Details
2.8.2 Sysmex Major Business
2.8.3 Sysmex IVD Infectious Diseases Product and Solutions
2.8.4 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Sysmex Recent Developments and Future Plans
2.9 Orasure
2.9.1 Orasure Details
2.9.2 Orasure Major Business
2.9.3 Orasure IVD Infectious Diseases Product and Solutions
2.9.4 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Orasure Recent Developments and Future Plans
2.10 Hologic
2.10.1 Hologic Details
2.10.2 Hologic Major Business
2.10.3 Hologic IVD Infectious Diseases Product and Solutions
2.10.4 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Hologic Recent Developments and Future Plans
2.11 Cepheid
2.11.1 Cepheid Details
2.11.2 Cepheid Major Business
2.11.3 Cepheid IVD Infectious Diseases Product and Solutions
2.11.4 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Cepheid Recent Developments and Future Plans
2.12 Qiagen
2.12.1 Qiagen Details
2.12.2 Qiagen Major Business
2.12.3 Qiagen IVD Infectious Diseases Product and Solutions
2.12.4 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Qiagen Recent Developments and Future Plans
2.13 Roche Diagnostics
2.13.1 Roche Diagnostics Details
2.13.2 Roche Diagnostics Major Business
2.13.3 Roche Diagnostics IVD Infectious Diseases Product and Solutions
2.13.4 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Roche Diagnostics Recent Developments and Future Plans
2.14 Siemens Healthcare
2.14.1 Siemens Healthcare Details
2.14.2 Siemens Healthcare Major Business
2.14.3 Siemens Healthcare IVD Infectious Diseases Product and Solutions
2.14.4 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Siemens Healthcare Recent Developments and Future Plans
2.15 Bio-Rad Laboratories
2.15.1 Bio-Rad Laboratories Details
2.15.2 Bio-Rad Laboratories Major Business
2.15.3 Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions
2.15.4 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IVD Infectious Diseases Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IVD Infectious Diseases by Company Revenue
3.2.2 Top 3 IVD Infectious Diseases Players Market Share in 2023
3.2.3 Top 6 IVD Infectious Diseases Players Market Share in 2023
3.3 IVD Infectious Diseases Market: Overall Company Footprint Analysis
3.3.1 IVD Infectious Diseases Market: Region Footprint
3.3.2 IVD Infectious Diseases Market: Company Product Type Footprint
3.3.3 IVD Infectious Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IVD Infectious Diseases Consumption Value and Market Share by Type (2019-2024)
4.2 Global IVD Infectious Diseases Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IVD Infectious Diseases Consumption Value Market Share by Application (2019-2024)
5.2 Global IVD Infectious Diseases Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America IVD Infectious Diseases Consumption Value by Type (2019-2030)
6.2 North America IVD Infectious Diseases Consumption Value by Application (2019-2030)
6.3 North America IVD Infectious Diseases Market Size by Country
6.3.1 North America IVD Infectious Diseases Consumption Value by Country (2019-2030)
6.3.2 United States IVD Infectious Diseases Market Size and Forecast (2019-2030)
6.3.3 Canada IVD Infectious Diseases Market Size and Forecast (2019-2030)
6.3.4 Mexico IVD Infectious Diseases Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe IVD Infectious Diseases Consumption Value by Type (2019-2030)
7.2 Europe IVD Infectious Diseases Consumption Value by Application (2019-2030)
7.3 Europe IVD Infectious Diseases Market Size by Country
7.3.1 Europe IVD Infectious Diseases Consumption Value by Country (2019-2030)
7.3.2 Germany IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.3 France IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.5 Russia IVD Infectious Diseases Market Size and Forecast (2019-2030)
7.3.6 Italy IVD Infectious Diseases Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region
8.3.1 Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2019-2030)
8.3.2 China IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.3 Japan IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.4 South Korea IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.5 India IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IVD Infectious Diseases Market Size and Forecast (2019-2030)
8.3.7 Australia IVD Infectious Diseases Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America IVD Infectious Diseases Consumption Value by Type (2019-2030)
9.2 South America IVD Infectious Diseases Consumption Value by Application (2019-2030)
9.3 South America IVD Infectious Diseases Market Size by Country
9.3.1 South America IVD Infectious Diseases Consumption Value by Country (2019-2030)
9.3.2 Brazil IVD Infectious Diseases Market Size and Forecast (2019-2030)
9.3.3 Argentina IVD Infectious Diseases Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country
10.3.1 Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2019-2030)
10.3.2 Turkey IVD Infectious Diseases Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IVD Infectious Diseases Market Size and Forecast (2019-2030)
10.3.4 UAE IVD Infectious Diseases Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 IVD Infectious Diseases Market Drivers
11.2 IVD Infectious Diseases Market Restraints
11.3 IVD Infectious Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IVD Infectious Diseases Industry Chain
12.2 IVD Infectious Diseases Upstream Analysis
12.3 IVD Infectious Diseases Midstream Analysis
12.4 IVD Infectious Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global IVD Infectious Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IVD Infectious Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global IVD Infectious Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global IVD Infectious Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD IVD Infectious Diseases Product and Solutions
Table 8. BD IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BD Recent Developments and Future Plans
Table 10. BioMerieux Company Information, Head Office, and Major Competitors
Table 11. BioMerieux Major Business
Table 12. BioMerieux IVD Infectious Diseases Product and Solutions
Table 13. BioMerieux IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioMerieux Recent Developments and Future Plans
Table 15. Abbott Company Information, Head Office, and Major Competitors
Table 16. Abbott Major Business
Table 17. Abbott IVD Infectious Diseases Product and Solutions
Table 18. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Recent Developments and Future Plans
Table 20. Quidel Company Information, Head Office, and Major Competitors
Table 21. Quidel Major Business
Table 22. Quidel IVD Infectious Diseases Product and Solutions
Table 23. Quidel IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Quidel Recent Developments and Future Plans
Table 25. Gen-Probe Company Information, Head Office, and Major Competitors
Table 26. Gen-Probe Major Business
Table 27. Gen-Probe IVD Infectious Diseases Product and Solutions
Table 28. Gen-Probe IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Gen-Probe Recent Developments and Future Plans
Table 30. Abbott Company Information, Head Office, and Major Competitors
Table 31. Abbott Major Business
Table 32. Abbott IVD Infectious Diseases Product and Solutions
Table 33. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Abbott Recent Developments and Future Plans
Table 35. Danaher Company Information, Head Office, and Major Competitors
Table 36. Danaher Major Business
Table 37. Danaher IVD Infectious Diseases Product and Solutions
Table 38. Danaher IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Danaher Recent Developments and Future Plans
Table 40. Sysmex Company Information, Head Office, and Major Competitors
Table 41. Sysmex Major Business
Table 42. Sysmex IVD Infectious Diseases Product and Solutions
Table 43. Sysmex IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sysmex Recent Developments and Future Plans
Table 45. Orasure Company Information, Head Office, and Major Competitors
Table 46. Orasure Major Business
Table 47. Orasure IVD Infectious Diseases Product and Solutions
Table 48. Orasure IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Orasure Recent Developments and Future Plans
Table 50. Hologic Company Information, Head Office, and Major Competitors
Table 51. Hologic Major Business
Table 52. Hologic IVD Infectious Diseases Product and Solutions
Table 53. Hologic IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Hologic Recent Developments and Future Plans
Table 55. Cepheid Company Information, Head Office, and Major Competitors
Table 56. Cepheid Major Business
Table 57. Cepheid IVD Infectious Diseases Product and Solutions
Table 58. Cepheid IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cepheid Recent Developments and Future Plans
Table 60. Qiagen Company Information, Head Office, and Major Competitors
Table 61. Qiagen Major Business
Table 62. Qiagen IVD Infectious Diseases Product and Solutions
Table 63. Qiagen IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Qiagen Recent Developments and Future Plans
Table 65. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 66. Roche Diagnostics Major Business
Table 67. Roche Diagnostics IVD Infectious Diseases Product and Solutions
Table 68. Roche Diagnostics IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Roche Diagnostics Recent Developments and Future Plans
Table 70. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 71. Siemens Healthcare Major Business
Table 72. Siemens Healthcare IVD Infectious Diseases Product and Solutions
Table 73. Siemens Healthcare IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Siemens Healthcare Recent Developments and Future Plans
Table 75. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 76. Bio-Rad Laboratories Major Business
Table 77. Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions
Table 78. Bio-Rad Laboratories IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Bio-Rad Laboratories Recent Developments and Future Plans
Table 80. Global IVD Infectious Diseases Revenue (USD Million) by Players (2019-2024)
Table 81. Global IVD Infectious Diseases Revenue Share by Players (2019-2024)
Table 82. Breakdown of IVD Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in IVD Infectious Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key IVD Infectious Diseases Players
Table 85. IVD Infectious Diseases Market: Company Product Type Footprint
Table 86. IVD Infectious Diseases Market: Company Product Application Footprint
Table 87. IVD Infectious Diseases New Market Entrants and Barriers to Market Entry
Table 88. IVD Infectious Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global IVD Infectious Diseases Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global IVD Infectious Diseases Consumption Value Share by Type (2019-2024)
Table 91. Global IVD Infectious Diseases Consumption Value Forecast by Type (2025-2030)
Table 92. Global IVD Infectious Diseases Consumption Value by Application (2019-2024)
Table 93. Global IVD Infectious Diseases Consumption Value Forecast by Application (2025-2030)
Table 94. North America IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 124. IVD Infectious Diseases Raw Material
Table 125. Key Suppliers of IVD Infectious Diseases Raw Materials
Table 1. Global IVD Infectious Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IVD Infectious Diseases Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global IVD Infectious Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global IVD Infectious Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD IVD Infectious Diseases Product and Solutions
Table 8. BD IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BD Recent Developments and Future Plans
Table 10. BioMerieux Company Information, Head Office, and Major Competitors
Table 11. BioMerieux Major Business
Table 12. BioMerieux IVD Infectious Diseases Product and Solutions
Table 13. BioMerieux IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. BioMerieux Recent Developments and Future Plans
Table 15. Abbott Company Information, Head Office, and Major Competitors
Table 16. Abbott Major Business
Table 17. Abbott IVD Infectious Diseases Product and Solutions
Table 18. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Abbott Recent Developments and Future Plans
Table 20. Quidel Company Information, Head Office, and Major Competitors
Table 21. Quidel Major Business
Table 22. Quidel IVD Infectious Diseases Product and Solutions
Table 23. Quidel IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Quidel Recent Developments and Future Plans
Table 25. Gen-Probe Company Information, Head Office, and Major Competitors
Table 26. Gen-Probe Major Business
Table 27. Gen-Probe IVD Infectious Diseases Product and Solutions
Table 28. Gen-Probe IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Gen-Probe Recent Developments and Future Plans
Table 30. Abbott Company Information, Head Office, and Major Competitors
Table 31. Abbott Major Business
Table 32. Abbott IVD Infectious Diseases Product and Solutions
Table 33. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Abbott Recent Developments and Future Plans
Table 35. Danaher Company Information, Head Office, and Major Competitors
Table 36. Danaher Major Business
Table 37. Danaher IVD Infectious Diseases Product and Solutions
Table 38. Danaher IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Danaher Recent Developments and Future Plans
Table 40. Sysmex Company Information, Head Office, and Major Competitors
Table 41. Sysmex Major Business
Table 42. Sysmex IVD Infectious Diseases Product and Solutions
Table 43. Sysmex IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Sysmex Recent Developments and Future Plans
Table 45. Orasure Company Information, Head Office, and Major Competitors
Table 46. Orasure Major Business
Table 47. Orasure IVD Infectious Diseases Product and Solutions
Table 48. Orasure IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Orasure Recent Developments and Future Plans
Table 50. Hologic Company Information, Head Office, and Major Competitors
Table 51. Hologic Major Business
Table 52. Hologic IVD Infectious Diseases Product and Solutions
Table 53. Hologic IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Hologic Recent Developments and Future Plans
Table 55. Cepheid Company Information, Head Office, and Major Competitors
Table 56. Cepheid Major Business
Table 57. Cepheid IVD Infectious Diseases Product and Solutions
Table 58. Cepheid IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Cepheid Recent Developments and Future Plans
Table 60. Qiagen Company Information, Head Office, and Major Competitors
Table 61. Qiagen Major Business
Table 62. Qiagen IVD Infectious Diseases Product and Solutions
Table 63. Qiagen IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Qiagen Recent Developments and Future Plans
Table 65. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 66. Roche Diagnostics Major Business
Table 67. Roche Diagnostics IVD Infectious Diseases Product and Solutions
Table 68. Roche Diagnostics IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Roche Diagnostics Recent Developments and Future Plans
Table 70. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 71. Siemens Healthcare Major Business
Table 72. Siemens Healthcare IVD Infectious Diseases Product and Solutions
Table 73. Siemens Healthcare IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Siemens Healthcare Recent Developments and Future Plans
Table 75. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 76. Bio-Rad Laboratories Major Business
Table 77. Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions
Table 78. Bio-Rad Laboratories IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Bio-Rad Laboratories Recent Developments and Future Plans
Table 80. Global IVD Infectious Diseases Revenue (USD Million) by Players (2019-2024)
Table 81. Global IVD Infectious Diseases Revenue Share by Players (2019-2024)
Table 82. Breakdown of IVD Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in IVD Infectious Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key IVD Infectious Diseases Players
Table 85. IVD Infectious Diseases Market: Company Product Type Footprint
Table 86. IVD Infectious Diseases Market: Company Product Application Footprint
Table 87. IVD Infectious Diseases New Market Entrants and Barriers to Market Entry
Table 88. IVD Infectious Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global IVD Infectious Diseases Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global IVD Infectious Diseases Consumption Value Share by Type (2019-2024)
Table 91. Global IVD Infectious Diseases Consumption Value Forecast by Type (2025-2030)
Table 92. Global IVD Infectious Diseases Consumption Value by Application (2019-2024)
Table 93. Global IVD Infectious Diseases Consumption Value Forecast by Application (2025-2030)
Table 94. North America IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific IVD Infectious Diseases Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa IVD Infectious Diseases Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa IVD Infectious Diseases Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa IVD Infectious Diseases Consumption Value by Country (2025-2030) & (USD Million)
Table 124. IVD Infectious Diseases Raw Material
Table 125. Key Suppliers of IVD Infectious Diseases Raw Materials
LIST OF FIGURES
Figure 1. IVD Infectious Diseases Picture
Figure 2. Global IVD Infectious Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IVD Infectious Diseases Consumption Value Market Share by Type in 2023
Figure 4. Immunochemistry
Figure 5. Molecular Diagnostics
Figure 6. Global IVD Infectious Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. IVD Infectious Diseases Consumption Value Market Share by Application in 2023
Figure 8. Clinical Laboratories Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Global IVD Infectious Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global IVD Infectious Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market IVD Infectious Diseases Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global IVD Infectious Diseases Consumption Value Market Share by Region (2019-2030)
Figure 14. Global IVD Infectious Diseases Consumption Value Market Share by Region in 2023
Figure 15. North America IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 18. South America IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 20. Global IVD Infectious Diseases Revenue Share by Players in 2023
Figure 21. IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players IVD Infectious Diseases Market Share in 2023
Figure 23. Global Top 6 Players IVD Infectious Diseases Market Share in 2023
Figure 24. Global IVD Infectious Diseases Consumption Value Share by Type (2019-2024)
Figure 25. Global IVD Infectious Diseases Market Share Forecast by Type (2025-2030)
Figure 26. Global IVD Infectious Diseases Consumption Value Share by Application (2019-2024)
Figure 27. Global IVD Infectious Diseases Market Share Forecast by Application (2025-2030)
Figure 28. North America IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 29. North America IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 30. North America IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 31. United States IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 38. France IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific IVD Infectious Diseases Consumption Value Market Share by Region (2019-2030)
Figure 45. China IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 48. India IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 51. South America IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 52. South America IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 53. South America IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 62. IVD Infectious Diseases Market Drivers
Figure 63. IVD Infectious Diseases Market Restraints
Figure 64. IVD Infectious Diseases Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of IVD Infectious Diseases in 2023
Figure 67. Manufacturing Process Analysis of IVD Infectious Diseases
Figure 68. IVD Infectious Diseases Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Figure 1. IVD Infectious Diseases Picture
Figure 2. Global IVD Infectious Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IVD Infectious Diseases Consumption Value Market Share by Type in 2023
Figure 4. Immunochemistry
Figure 5. Molecular Diagnostics
Figure 6. Global IVD Infectious Diseases Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. IVD Infectious Diseases Consumption Value Market Share by Application in 2023
Figure 8. Clinical Laboratories Picture
Figure 9. Diagnostic Centers Picture
Figure 10. Global IVD Infectious Diseases Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global IVD Infectious Diseases Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Market IVD Infectious Diseases Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 13. Global IVD Infectious Diseases Consumption Value Market Share by Region (2019-2030)
Figure 14. Global IVD Infectious Diseases Consumption Value Market Share by Region in 2023
Figure 15. North America IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 16. Europe IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 17. Asia-Pacific IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 18. South America IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 19. Middle East and Africa IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 20. Global IVD Infectious Diseases Revenue Share by Players in 2023
Figure 21. IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 22. Global Top 3 Players IVD Infectious Diseases Market Share in 2023
Figure 23. Global Top 6 Players IVD Infectious Diseases Market Share in 2023
Figure 24. Global IVD Infectious Diseases Consumption Value Share by Type (2019-2024)
Figure 25. Global IVD Infectious Diseases Market Share Forecast by Type (2025-2030)
Figure 26. Global IVD Infectious Diseases Consumption Value Share by Application (2019-2024)
Figure 27. Global IVD Infectious Diseases Market Share Forecast by Application (2025-2030)
Figure 28. North America IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 29. North America IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 30. North America IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 31. United States IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 32. Canada IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 33. Mexico IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 34. Europe IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 35. Europe IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 36. Europe IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 37. Germany IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 38. France IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 39. United Kingdom IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 40. Russia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 41. Italy IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 42. Asia-Pacific IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 43. Asia-Pacific IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 44. Asia-Pacific IVD Infectious Diseases Consumption Value Market Share by Region (2019-2030)
Figure 45. China IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 46. Japan IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 47. South Korea IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 48. India IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 49. Southeast Asia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 50. Australia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 51. South America IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 52. South America IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 53. South America IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 54. Brazil IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 55. Argentina IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 56. Middle East and Africa IVD Infectious Diseases Consumption Value Market Share by Type (2019-2030)
Figure 57. Middle East and Africa IVD Infectious Diseases Consumption Value Market Share by Application (2019-2030)
Figure 58. Middle East and Africa IVD Infectious Diseases Consumption Value Market Share by Country (2019-2030)
Figure 59. Turkey IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 60. Saudi Arabia IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 61. UAE IVD Infectious Diseases Consumption Value (2019-2030) & (USD Million)
Figure 62. IVD Infectious Diseases Market Drivers
Figure 63. IVD Infectious Diseases Market Restraints
Figure 64. IVD Infectious Diseases Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of IVD Infectious Diseases in 2023
Figure 67. Manufacturing Process Analysis of IVD Infectious Diseases
Figure 68. IVD Infectious Diseases Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
